Position in MRNA
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$43,908
+$15,308 QoQ
Shares Held
627
+11.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#558
of 772 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JFS WEALTH ADVISORS, LLC holds $296,395 across 46 Biotechnology names. MRNA ranks #2 (14.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
101 | $50,169 | |
| 2 | MRNA |
Moderna, Inc.
This page
|
627 | $43,908 | |
| 3 | ARGX |
Argenx SE
|
36 | $33,399 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
40 | $24,941 | |
| 5 | EXEL |
Exelixis, Inc.
|
293 | $15,942 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
56 | $13,494 | |
| 7 | INCY |
Incyte Corp
|
117 | $13,263 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
40 | $12,041 |
All Filings in MRNA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,908 | 627 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $28,600 | 563 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $15,718 | 533 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $13,095 | 507 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $13,988 | 507 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $14,401 | 508 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $21,164 | 509 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $37,424 | 560 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $69,350 | 584 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $58,608 | 550 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $54,697 | 550 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $65,589 | 635 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $77,274 | 636 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $99,366 | 647 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $116,214 | 647 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $80,528 | 681 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $90,709 | 635 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $113,519 | 659 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $157,975 | 622 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $233,610 | 607 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $119,134 | 507 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $69,927 | 534 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $73,860 | 707 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $50,020 | 707 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $45,396 | 707 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $21,174 | 707 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||